ProKidney Corp.PROKNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P21
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -24.99% |
| Q2 2025 | -2.14% |
| Q1 2025 | 20.98% |
| Q4 2024 | -33.05% |
| Q3 2024 | 29.82% |
| Q2 2024 | 6.30% |
| Q1 2024 | 663.56% |
| Q4 2023 | -88.33% |
| Q3 2023 | 7.16% |
| Q2 2023 | -11.82% |
| Q1 2023 | 63.29% |
| Q4 2022 | -35.28% |
| Q3 2022 | 57.30% |
| Q2 2022 | -75.82% |
| Q1 2022 | 1155.69% |
| Q4 2021 | 29.29% |
| Q3 2021 | 33.81% |
| Q2 2021 | 0.23% |
| Q1 2021 | 22.90% |
| Q4 2020 | 0.00% |